Clinical trial
Cardiac Denervation Ablation Strategy for Severe Sinus Bradycardia
NCT06276816 is registered in ClinicalTrials.gov with China National Center for Cardiovascular Diseases as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Cardiac Denervation Ablation Strategy for Severe Sinus Bradycardia
- Lead sponsor
- China National Center for Cardiovascular Diseases
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- September 13, 2023
- Completion date
- December 30, 2024
- Enrollment
- 88 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
sinus bradycardia